Tuesday, 25 May 2021

Mesenchymal Stem Cells Market to Surpass USD 6.1 Billion by 2028: Grand View Research Inc.

 Mesenchymal Stem Cells Market Growth & Trends 

The global mesenchymal stem cells market size is expected to reach USD 6.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.6% from 2021 to 2028. Mesenchymal stem cells (MSCs) are set to gain popularity among healthcare professionals, to develop novel therapeutics, primarily targeted at the treatment of several immune-mediated disorders. MSCs have been acclaimed effective as a regenerative therapy for skeletal tissue repair and have recently gained traction across modulation of immune cells and endogenous tissues.

Expanding clinical applications of mesenchymal stem cells, strengthening the pipeline of these therapies, along with intensifying market competition are some of the key aspects driving the industry expansion of MSCs. The recent pandemic outbreak of COVID-19 is set to propel the clinical applications and investments done in this market space. For instance, in April 2020, Canada’s The Stem Cell Network (SCN) provided funding of USD 300,000 to the project targeted towards the evaluation of optimal dosage of MSCs, to design an effective therapeutic approach to reduce the impacts of respiratory disorders associated with SARS-CoV-2 infection.

Additionally, as stated by clinicaltrials.gov, 21 clinical trials reportedly incorporated MSCs in the management of COVID-19. Apart from the applications of MSCs in regenerative medicine and tissue engineering, the MSCs serve as a potent therapeutic approach for cancer treatment. As of February 2020, 25 clinical trials have been registered that employ MSCs in the treatment of several cancer indications. This is set to drive the mesenchymal stem cells market (MSCs) market.

Acknowledging the profitable opportunities posed by the market, key industry participants are focused towards initiating technological collaborations to strengthen their market presence. In August 2020, NantKwest Inc. collaborated with Generate Life Sciences Co. to develop a mesenchymal stem cell-based treatment against COVID-19. The latter company is providing with the MSCs derived from donated umbilical cord tissues.

Request a free sample copy or view report summary: Mesenchymal Stem Cells Market Report

Mesenchymal Stem Cells Market Report Highlights

  • Widespread use of bone marrow derived MSCs in several therapeutic applications has resulted in the segment’s dominance in 2020
  • More than 20.0% of clinical trials incorporate bone marrow MSCs, which is set to maintain the segment’s largest revenue share up to 2028
  • The cancer indication segment is expected to witness rapid growth through 2021 to 2028, attributed to the emergence of MSCs as a promising vehicle for anti-cancer drugs
  • This is attributed to the tumor tropism ability of MSCs and their ability to manage the predestination of tumor cells
  • Disease modelling application generated the highest revenue in 2020, owing to several advantages associated with MSCs such as the high capacity of expansion and self-renewal and reduced tumorigenic capacity, which makes them suitable across disease modelling applications
  • The kits, media, and reagents segment held a significant revenue share in 2020 owing to the presence of a substantial number of service providers and increasing demand in the market
  • The allogeneic segment dominated the market in 2020; Implantation of allogeneic mesenchymal stem cells serves as a promising tool for cell-based therapy
  • As of August 2019, more than 200 clinical trials have been reported for use of allogeneic MSCs, which is expected to propel the segment’s revenue generation capacity from 2021 to 2028
  • Apart from the availability of advanced research facilities and skilled professionals, favorable government initiatives and high R&D expenditure, active policies pertaining to cell therapies have contributed to the dominance of North America MSCs market in 2020
  • For instance, in August 2020, the Centers for Medicare and Medicaid Services proposed new policies that include cellular therapies, wherein, commercial insurance companies support private health plans associated with MSCs
  • The key players are engaged in exploring MSC therapy to its highest potential across different emerging applications, contributing to market growth
  • For instance, in July 2020, Promedica presented positive results from its study that evaluated the use of allogeneic MSCs in COVID-19 patients. The study was conducted under the U.S. FDA’s Emergency Investigational New Drug (IND) approval

Access Press Release@ https://www.grandviewresearch.com/press-release/global-mesenchymal-stem-cells-market

Mesenchymal Stem Cells Market Segmentation

Grand View Research has segmented the global mesenchymal stem cells market on the basis of products and services, type, source of isolation, indication, application, and region:

Mesenchymal Stem Cells Products & Services Outlook (Revenue, USD Million, 2017 - 2028)

  • Products
    • Workflow Type
      • Cell Sourcing & Isolation
      • Culture & Cryopreservation
      • Differentiation
      • Characterization
    • Product Type
      • Cells & Cell Lines
      • Kits, Media, & Reagents
      • Others
    • Services

Mesenchymal Stem Cells Type Outlook (Revenue, USD Million, 2017 - 2028)

  • Autologous
  • Allogeneic

Mesenchymal Stem Cells Source of Isolation Outlook (Revenue, USD Million, 2017 - 2028)

  • Bone Marrow
  • Cord Blood
  • Peripheral Blood
  • Fallopian Tube
  • Fetal Liver
  • Lung
  • Adipose Tissues

Mesenchymal Stem Cells Indication Outlook (Revenue, USD Million, 2017 - 2028)

  • Bone And Cartilage Repair
  • Cardiovascular Disease
  • Inflammatory And Immunological Diseases
  • Liver Diseases
  • Cancer
  • GvHD
  • Others

Mesenchymal Stem Cells Application Outlook (Revenue, USD Million, 2017 - 2028)

  • Disease Modelling
  • Drug Development & Discovery
  • Stem Cell Banking
  • Tissue Engineering
  • Toxicology Studies
  • Others

Mesenchymal Stem Cells Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
    • Italy
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia

List of Key Players of Mesenchymal Stem Cells (MSCs) Market

  • Thermo Fisher Scientific, Inc.
  • Cell Applications, Inc.
  • Cyagen Biosciences Inc.
  • Axol Biosciences Ltd.
  • Cytori Therapeutics Inc
  • STEMCELL Technologies Inc
  • Celprogen Inc
  • BrainStorm Cell Therapeutics Inc.
  • Stemedica Cell Technologies Inc
  • Merck KGaA (MilliporeSigma)
  • Smith+Nephew
  • Lonza AG
  • PromoCell GmbH
  • ScienCell Research Laboratories
  • American Type Culture Collection

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Monday, 24 May 2021

Packaged Salad Market Plying for Significant Growth During 2021-2028: Grand View Research Inc.

 Packaged Salad Market Growth & Trends

The global packaged salad market size is expected to reach USD 20.30 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.2% from 2021 to 2028. The growing trend of a healthy lifestyle is one of the key factors that will drive the market over the forecast period. Furthermore, the busy schedules of the millennials leave less time for cooking and various other kitchen chores, and thus people have been demanding ready-to-eat salads.

In recent years, it has been noted that consumers have been opting for vegetables and similar raw ingredients instead of fast foods and processed foods. The increasing focus on weight management owing to rising obesity levels is propelling the demand for packaged salads among consumers around the world. The low caloric content of packaged salads makes them ideal for weight management.

The vegetarian product segment dominated the market with a 67.4% share in 2020. The demand for vegetarian products is significantly growing owing to the rising vegan population around the world. The growing awareness regarding the high carbon footprint of the meat industry, along with animal health and animal cruelty, is compelling an increasing number of consumers to opt for vegetarian products instead.

Organically processed products are expected to expand at the highest CAGR of 8.6% over the forecast period. Organically processed products are generally perceived to contain more nutrients and antioxidants than conventional counterparts. Health-conscious consumers who focus on reducing their exposure to artificial chemicals and antibiotic-resistant bacteria usually prefer organically processed products to conventionally processed alternatives.

Mergers & acquisitions, new product launches, and production capacity expansion are some of the key strategic initiatives taken up by the companies to gain a competitive advantage over other players. In May 2020, Dole Food Company Inc. debuted its DOLE FreshTakes Ready-To-Eat Salad Bowls in the Western U.S. after its successful debut in the Eastern U.S. in 2019.

Request a free sample copy or view report summary: Packaged Salad Market Report

Packaged Salad Market Report Highlights

  • The packaged kits type segment is anticipated to register the fastest CAGR of 8.4% from 2021 to 2028. The increasingly hectic lifestyles and rising number of single-person households have been driving the segment
  • The online distribution channel is expected to register the fastest CAGR of 9.0% from 2021 to 2028 due to the increasing presence of online retailers
  • North America led the market by accounting for more than 41.0% in 2020. The busy lifestyle of the consumers has been propelling the demand for these conveniently packaged salads in the region
  • The vegetarian product segment held the largest share of 67.4% in 2020 owning to the growing number of health-conscious consumers across the globe

Access Press Release@ https://www.grandviewresearch.com/press-release/global-packaged-salad-market

Packaged Salad Market Segmentation

Grand View Research has segmented the global packaged salad market on the basis of product, processing, type, distribution channel, and region:

Packaged Salad Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Vegetarian
  • Non-vegetarian

Packaged Salad Processing Outlook (Revenue, USD Million, 2016 - 2028)

  • Organic
  • Conventional

Packaged Salad Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Packaged Greens
  • Packaged Kits

Packaged Salad Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

  • Offline
  • Online

Packaged Salad Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • France
  • Asia Pacific
    • China
    • India
    • Australia
  • Central & South America
    • Brazil
  • Middle East & Africa

List of Key Players of Packaged Salad Market

  • BrightFarms, Inc.
  • Dole Food Company, Inc.
  • Earthbound Farm
  • Eat Smart (Curation Foods)
  • Fresh Express, Incorporated
  • Misionero
  • Gotham Greens Holdings, LLC
  • Mann Packing Co., Inc.
  • Bonduelle
  • Organicgirl, LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Neurovascular Devices Market Top Companies, Trends and Growth Factors Details for Business Development by 2028

 

Neurovascular Devices Market Growth & Trends

The global neurovascular devices market size is anticipated to reach USD 4.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.9% from 2021 to 2028. Increasing incidence of neurological disorders such as stroke, brain aneurysm, cerebral artery stenosis, are fueling the market growth. For instance, the Stroke Association states, more than 100,000 people suffer from stroke every year in the U.K. Thereby, the numbers reveal the high demand for neurovascular equipment, thus leading to market growth.

Decreased postoperative pain, a speedy recovery is leading to increasing adoption of minimally invasive surgeries and triggering the growth of R&D in this field. The endovascular coiling used for the treatment of intracranial aneurysm is one of the minimally invasive procedures and is widely recommended by physicians. As compared to the bare-platinum coils, HydroCoils (MicroVention, Tustin, California, USA) has enabled the treatment of more complex aneurysmal structures with lower recurrence rates. Thus, the rising demand for minimally invasive procedures is further fueling the market growth.

Patients suffering from Covid-19 have subsequently exhibited neurologic symptoms that are expected to create a favorable environment for market growth. For instance, as per the study in Lancet, 1 in 3 COVID patients who recovered have neurological and mental health disorders. The study was led by Oxford University researchers and included over 2 lakh COVID patients who recovered from the disease. Such instances will surge the demand for neurovascular equipment. Thus, COVID-19 might have a positive impact on the market in the coming years.

Request a free sample copy or view report summary: Neurovascular Devices Market Report

Neurovascular Devices Market Report Highlights

  • The cerebral embolization and aneurysm coiling devices segment dominated the market in 2020 due to soaring incidence of cerebral artery stenosis, increase in the number of technologically advanced product launches by key players and surge in R&D
  • Based on therapeutic application, the stroke segment dominated the market in 2020 due to escalating prevalence of stroke globally and the launch of technologically advanced products by the market players
  • North America led the market with the maximum revenue share in 2020 owing to the rising prevalence of stroke and brain aneurysm, growing disposable income, and presence of major players in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-neurovascular-devices-market-size-report

Neurovascular Devices Market Segmentation

Grand View Research has segmented the global neurovascular devices market on the basis of device, therapeutic application, and region:

Neurovascular Device Outlook (Revenue, USD Million, 2016 - 2028)

  • Cerebral Embolization and Aneurysm Coiling Devices
    • Embolic coiling
    • Flow Diversion Devices
    • Liquid Embolic agents
  • Cerebral Angioplasty and Stenting Systems
    • Carotid Artery Stents
    • Embolic Protection Systems
  • Neurothrombectomy Devices
    • Clot Retrieval Devices
    • Suction Devices
    • Vascular Snares
  • Support Devices
    • Micro Catheters
    • Micro Guidewires

Neurovascular Device Therapeutic Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Stroke
  • Cerebral Artery Stenosis
  • Cerebral Aneurysm
    • Aneurysmal Subarachnoid Hemorrhage
    • Others
  • Others

Neurovascular Device Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Neurovascular Devices Market

  • Medtronic
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Johnson & Johnson Services, Inc.
  • MicroVention, Inc.
  • Codman Neuro

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Track and Trace Solutions Market is Expected to Grow at a CAGR of 19.0% during the Forecast Period: Grand View Research Inc.

 

Track And Trace Solutions Market Growth & Trends

The global track and trace solutions market size is expected to reach USD 9.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.0% from 2021 to 2028. The growth is attributed majorly due to the increasing focus of pharmaceutical and biopharmaceutical companies on ensuring brand protection from counterfeit products and theft. The deployment of a track and trace system helps manufacturers enhance distribution channel efficiency and reduces the frequency of counterfeit products.

Furthermore, the rising adoption of track and trace systems by healthcare manufacturers would fuel the market growth in the long run. The introduction of advanced technology, such as RFID, provides fast reading and delivers high levels of security. However, the deployment cost of serialization and aggregation methods, as well as the lack of common regulations and standards, may hamper the market growth in few developing geographies.

US CBP and customs of other member countries as well as by the World Customs Organization reported the seizures of false coronavirus tests and personal protective equipment for example facemasks and hand sanitizers. For instance, in May 2020, Smartrac teamed up with SUKU to validate COVID-19 testing kits and personal protective equipment to permit prompt verification and deliver end-to-end supply chain transparency. Hence, it is estimated that the market will witness lucrative growth opportunities due to the COVID-19 outbreak.

Request a free sample copy or view report summary: Track And Trace Solutions Market Report

Track And Trace Solutions Market Report Highlights

  • The software solution was the largest revenue-generating segment of the market in 2020. This contribution is mainly because of the regulatory mandates for the execution of serialization and aggregation in the healthcare sector
  • The serialization solution was the largest grossing segment in 2020. Increasing application of serialization in pharmaceuticals and medical devices packaging will be a vital factor contributing to the growth of the segment
  • The RFID segment is expected to exhibit the fastest growth rate during the study period. The key factors attributing to the growth of the segment are technological advantages, such as high durability and reusability, more data storage capacity, and no requirement of the line of sight
  • North America dominated the market in 2020. The rising implementation of regulatory standards and regulations along with the high adoption rate of track and trace systems by consumers is anticipated to contribute to the growth of the market in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-track-trace-solutions-market

Track And Trace Solutions Market Segmentation

Grand View Research has segmented the global track and trace solutions market on the basis of product, technology, application, end-use, and region:

Track & Trace Solution Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Hardware Systems
    • Printing & marking
    • Monitoring & verification
    • Labeling
    • Others
  • Software Solutions
    • Plant manager software
    • Line controller software
    • Bundle tracking software
    • Others

Track & Trace Solution Technology Outlook (Revenue, USD Million, 2016 - 2028)

  • Barcodes
  • RFID

Track & Trace Solution Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Serialization Solutions
    • Bottle Serialization
    • Label Serialization
    • Carton Serialization
    • Data Matrix Serialization
  • Aggregation Solutions
    • Bundle Aggregation
    • Case Aggregation
    • Pallet Aggregation

Track & Trace Solution End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Pharmaceutical & biopharmaceutical Companies    
  • Medical Device Companies   
  • Healthcare Others
  • Food and Beverage
  • Consumer Goods
  • Luxury Goods

Track & Trace Solution Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
    • Switzerland
    • Belgium
    • Russia
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Egypt

List of Key Players of Track And Trace Solutions Market

  • Axway
  • Mettler-Toledo International, Inc.
  • Optel Vision
  • TraceLink, Inc.
  • Adents International
  • Antares Vision srl
  • Siemens AG
  • Seidenader Maschinenbau GmbH
  • ACG Worldwide
  • Systech, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Companion Animal Health Market Poised to Expand at a Robust Pace Over 2028: Grand View Research Inc.

 Companion Animal Health Market Growth & Trends

The global companion animal health market size is anticipated to reach USD 37.49 billion by 2028, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 9.2% from 2021 to 2028. Growing pet adoption, rising cases of acute & chronic health conditions in pets, and availability of pet insurance are the factors responsible for the growth of this market.

Growing investments and strategic initiatives by market players to develop advanced solutions for pet care is another key contributor to the growth of the market. For instance, in February 2020, Boehringer Ingelheim received approval for Aservo Equihaler, which is its first therapy for severe equine asthma.

Furthermore, the rising adoption of pet insurance is anticipated to fuel the market growth. As per The Holland Insurance Company Pty. Ltd., 20% of GenY and 12% of baby boomer pet owners have pet insurances in Australia. The pet insurance industry is also growing steadily in countries, such as India. These factors, combined with the humanization of pets and increasing pet health concerns, are expected to increase the demand for pet health products and services.

The market was impacted by the Covid-19 pandemic. Market participants had to face several challenges, such as demand slowdown, supply chain disruptions, and operational hurdles, due to the changing norms and restrictions. The pandemic created working capital pressures across the commercial value chain. However, the growing attachment of pet owners to their pets during this pandemic resulted in increased spending on pet healthcare. This has positively impacted the industry development.

The market is highly competitive and companies are undertaking various business strategies to sustain the heavy competition. As per its March 2020 press release, Ceva, a French global veterinary health company, focused on its inventory planning to ensure continuous product availability during the pandemic. The pre-availability of several months of safety stocks of the company’s strategic vaccines and pharmaceutical products created an added buffer to combat any supply chain interruptions.

Request a free sample copy or view report summary: Companion Animal Health Market Report

Companion Animal Health Market Report Highlights

  • The pharmaceuticals product segment held the largest revenue share in 2020. Ongoing advancements and research in drug formulations is the key growth-driving factor for the segment
  • The diagnostics segment is expected to grow at an exponential rate owing to increasing cases of zoonotic infections, which is likely to boost the need for the establishment of diagnostic laboratories and Point-of-Care (PoC) testing
  • The veterinary hospitals & clinics end-use segment accounted for the largest share in 2020
  • This growth can be credited to an increasing number of hospitals and clinics and the availability of a wide range of treatments and diagnostic options for pets in these healthcare settings
  • North America led the market in 2020 owing to the presence of major players and increasing prevalence of acute & chronic diseases in pets
  • Asia Pacific is expected to be the fastest-growing regional market during the forecast period due to rising pet ownership and pet health concerns

Access Press Release@ https://www.grandviewresearch.com/press-release/global-companion-animal-health-market

Companion Animal Health Market Segmentation

Grand View Research has segmented the global companion animal health market on the basis of animal type, product, distribution channel, end-use, and region:

Companion Animal Health Animal Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Dogs
  • Equine
  • Cats
  • Others

Companion Animal Health Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Vaccines
  • Pharmaceuticals
    • OTC
    • Prescription
  • Feed Additives
  • Diagnostics
  • Others

Companion Animal Health Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

  • Retail
  • E-commerce
  • Hospital Pharmacies

Companion Animal Health End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • PoC/In-house Testing
  • Veterinary Hospitals & Clinics
  • Others

Companion Animal Health Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Russia
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Malaysia
    • Singapore
    • Thailand
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey
    • Iran
    • UAE
    • Israel

List of Key Players of Companion Animal Health Market

  • Merck & Co., Inc.
  • Ceva
  • Vetoquinol S.A.
  • Zoetis
  • Boehringer Ingelheim International GmbH
  • Elanco
  • Virbac
  • IDEXX Laboratories, Inc.
  • Indian Immunologicals Ltd.
  • Agrolabo S.p.A

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Personalized Retail Nutrition & Wellness Market to Raise at CAGR of 7.9% from 2021 to 2028: Grand View Research Inc.

 

Personalized Retail Nutrition And Wellness Market Growth & Trends

The global personalized retail nutrition and wellness market size is expected to reach USD 3.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.9% from 2021 to 2028. The market growth can be attributed to the factors such as driving nutrition strategies, growing focus on nutrigenomics and nutrigenetics, a shift in the healthcare paradigm, and integration of data science for the development of innovative personalized nutrition.

In addition, nutrigenomics is gaining momentum owing to the rising number of studies for understanding the interrelation of nutrients with an individual’s genetic make-up. For instance, in May 2020, researchers revealed the role of flavonol intake in cardiometabolic diseases with the application of systematic bioinformatics analysis. The analysis revealed genes that are involved in leukocyte adhesion, lipid metabolism, and transendothelial migration. In addition, the study also analyzed the nutrigenomic effects of the compound in intestinal cells and their role in the metabolism of circulating lipoproteins.

Moreover, the companies operating in the market for personalized retail nutrition and wellness are heavily investing in bringing innovative solutions for sufficing nutritional diet in individuals, which is further contributing to market growth. Companies are investing in enhancing technologies that can help in the development of new product lines related to microbiota, nutrition, and digital health.

For instance, in November 2020, ADM Ventures announced its investment in Seventure’s Health For Life Capital (HFLC) Fund II. The company works with the Seventure team for identifying opportunities with the application of microbiome solutions for developing dietary supplements and other food and beverage applications. Hence, companies are extensively discovering and leveraging new nutritional ingredients for treating chronic diseases and common ailments.

Furthermore, the COVID-19 pandemic has a positive impact on the growth of the market for personalized retail nutrition and wellness. The demand for vitamins, minerals, and supplements is growing at an exponential rate owing to its potential role in the management of COVID-19. Several vitamins and minerals such as vitamins C, vitamin D, and zinc, have immunomodulatory functions and have a vital role in preserving physical tissue barriers. Hence, the demand for such nutrients for optimizing the immune system to prevent or lower the risk of COVID-19 infection is further contributing to the growth of the market for personalized retail nutrition and wellness. 

Request a free sample copy or view report summary: Personalized Retail Nutrition And Wellness Market Report

Personalized Retail Nutrition And Wellness Market Report Highlights

  • The repeat recommendation segment accounted for the largest revenue share in 2020 owing to the rising launch of commercial apps for monitoring an individual’s lifestyle and health
  • In the repeat recommendation segment, the functional foods segment dominated the market in 2020 owing to the high adoption of commercially available products for analyzing lifestyle patterns of the patients
  • The orthopedics, musculoskeletal, and spine segment held a substantial market share in 2020 due to the high demand for nutrient-based recommendations for the management or prevention of chronic diseases such as cardiovascular disease, obesity, and diabetes
  • In the fixed recommendation segment, the dietary supplements and nutraceuticals segment is expected to witness lucrative growth owing to the growing incidence of lifestyle-based diseases
  • North America held the largest revenue share in 2020. Growth in this region is owing to the presence of key players and extensive R&D activities
  • In Asia Pacific, the market is expected to witness significant growth over the forecast period owing to the reducing sequencing price and nutrigenomic testing, making it more accessible to population across the region
  • Companies operating in the market are launching new personalized nutrition products. For instance, in April 2020, Nestlé launched NESQINO, a personalized healthy drink series made from 100 percent natural ingredients

Access Press Release@ https://www.grandviewresearch.com/press-release/global-personalized-retail-nutrition-wellness-market

Personalized Retail Nutrition And Wellness Market Segmentation

Grand View Research has segmented the global personalized retail nutrition and wellness market based on recommendation and region:

Personalized Retail Nutrition & Wellness Recommendation Outlook (Revenue, USD Million, 2017 - 2028)

  • Fixed Recommendation
    • Dietary Supplements & Nutraceuticals
      • Vitamins
      • Proteins
      • Minerals
      • Amino Acids
      • Enzymes
      • Other dietary supplements & nutraceuticals
    • Functional Foods
      • Proteins
      • Vitamins
      • Dietary Fibers
      • Fatty Acids
      • Minerals
      • Prebiotics & Probiotics
      • Carotenoids
    • Traditional Botanicals
  • Repeat Recommendation
    • Dietary Supplements & Nutraceuticals
      • Vitamins
      • Proteins
      • Minerals
      • Amino Acids
      • Enzymes
      • Other dietary supplements & nutraceuticals
    • Functional Foods
      • Proteins
      • Vitamins
      • Dietary Fibers
      • Fatty Acids
      • Minerals
      • Prebiotics & Probiotics
      • Carotenoids
    • Traditional Botanicals
  • Continuous Recommendation
    • Dietary Supplements & Nutraceuticals
      • Vitamins
      • Proteins
      • Minerals
      • Amino Acids
      • Enzymes
      • Other dietary supplements & nutraceuticals
    • Functional Foods
      • Proteins
      • Vitamins
      • Dietary Fibers
      • Fatty Acids
      • Minerals
      • Prebiotics & Probiotics
      • Carotenoids
    • Traditional Botanicals

Personalized Retail Nutrition & Wellness Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • France
    • Germany
    • Spain
    • Italy
    • Switzerland
    • UK.
    • Russia
    • Poland
    • Hungary
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Indonesia
    • Philippines
    • Vietnam
  • Latin America
    • Brazil
    • Mexico
    • Ecuador
  • Middle East & Africa
    • Saudi Arabia
    • Iran
    • South Africa
    • Turkey

List of Key Players of Personalized Retail Nutrition And Wellness Market

  • The Nature’s Bounty Co.
  • Bayer AG
  • PlateJoy
  • Better Therapeutics, Inc
  • Tracxn Technologies
  • Viome (Habit Food Personalized, LLC)
  • BitBite Inc.
  • Noom, Inc.
  • Savor Health
  • Foodsmart, Inc.
  • GLUCOVATION, INC.
  • Healbe
  • AIRO Health Care (Pty) Ltd.
  • Nutrigenomix
  • DNAfit
  • BiogeniQ Inc.
  • Vitagene
  • Consumer Physics
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Herbalife International of America, Inc.
  • Reckitt Benckiser Group PLC.
  • DowDuPont
  • Tellspec
  • Cargill, Incorporated

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Consumer Genomics Market Competitive Insight and Key Drivers 2021 to 2028: Grand View Research Inc.

 Consumer Genomics Market Growth & Trends

The global consumer genomics market size is projected to reach USD 8.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.4% from 2021 to 2028. Technological advances in genetic research have helped to raise awareness among physicians as well as consumers pertaining to the use of gene-based testing.

Genomics testing enables the determination of common traits by studying a DNA molecule, predictions about health, and offers evidence of a person’s ancestry. Several companies are providing DNA tests directly to customers by which they have access to their genetic information without involving the healthcare professional. Rising awareness about DNA testing has driven the adoption rate, which in turn provides healthy growth prospects for the implementation of DNA tests in home settings.

The continuously declining costs of genotyping have resulted in direct-to-consumer services becoming more accessible to the average consumer as DNA testing services are delivered by key companies. Many key participants are focusing majorly on building partnerships and collaborations with physicians and healthcare systems to inflate their current marketplace.

Request a free sample copy or view report summary: Consumer Genomics Market Report

Consumer Genomics Market Report Highlights

  • The genetic relatedness segment accounted for the largest revenue generation in 2020 and is anticipated to remain dominant throughout the forecast period
  • Genetic relatedness involves the determination of hereditary or the genetic transfer of traits from parents to their offspring
  • These tests help analyze repetitive DNA regions known as short tandem repeats for the determination of a likelihood of paternity
  • The lifestyle, wellness, and nutrition segment is expected to witness the fastest CAGR as consumer genomics tests are claimed to provide personalized nutrition based on an individual’s genotype
  • For patients with rare genetic disorders such as galactosemia and lactose intolerance, a customized diet is recommended
  • Growing public interest for personalized health has fueled the adoption of nutrigenetic testing services, specifically for optimizing nutrition
  • Hence, personalized nutrition is employed to maintain or improve health by using genetic, clinical, and dietary information to provide precise and more efficacious personalized healthy recommendations
  • North America is estimated to capture the largest market share owing to the local presence of key industry participants such as 23andMe and AncestryDNA, and the commercialization of FDA approved kits 
  • Due to growing investments and skills, in Asia Pacific, the market is expected to grow with the fastest CAGR
  • This can majorly be attributed to the advent of knowledge-based innovations and entry of investors focused on personalized genetic screening as well as the presence of research funding agencies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-consumer-genomics-market

Consumer Genomics Market Segmentation

Grand View Research has segmented the global consumer genomics market on the basis of application and region:

Consumer Genomics Application Outlook (Revenue, USD Million, 2017 - 2028)

  • Genetic Relatedness
  • Diagnostics
  • Lifestyle, Wellness, & Nutrition
  • Ancestry
  • Reproductive Health
  • Personalized Medicine & Pharmacogenetic testing
  • Sports Nutrition & Health
  • Others

Consumer Genomics Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • France
    • UK.
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • Australia
    • India
    • Singapore
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia

List of Key Players of Consumer Genomics Market

  • Ancestry
  • Gene By Gene, Ltd. (FamilyTree DNA)
  • 23andMe, Inc.
  • Color Genomics, Inc
  • Myriad Genetics, Inc
  • Mapmygenome
  • Positive Biosciences, Ltd
  • Futura Genetics
  • Helix OpCo LLC
  • MyHeritage Ltd.
  • Pathway Genomics
  • Veritas
  • Amgen, Inc.
  • Xcode Life
  • Diagnomics, Inc.
  • Toolbox Genomics
  • SomaLogic, Inc.
  • inui Health (formerly Scanadu)
  • AgeCurve
  • QuickCheck Health
  • Biomeb
  • Metabolomic Discoveries GmbH
  • Illumina, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Commercial Refrigeration Equipment Market is Anticipated to Upgrade $43.16 Billion Revenue By 2028

 

Commercial Refrigeration Equipment Market Growth & Trends

The global commercial refrigeration equipment market size is estimated to reach USD 43.16 billion by 2028, registering an estimated CAGR of 4.2% from 2021 to 2028, according to a new report by Grand View Research, Inc. The increase in demand for frozen food items and the thriving hospitality and tourism industries are some of the factors driving the market growth.

The growing environmental concerns related to the emission of harmful refrigerants such as Chlorofluorocarbons (CFC) and Hydro-chlorofluorocarbons (HCFC) have led to the implementation of regulations favoring the use of efficient alternatives in commercial refrigeration equipment globally. Under its Clean Air Act, the U.S. Environment Protection Agency (EPA) has mandated the regularized use of low Global Warming Potential (GWP) refrigerants in the equipment for the commercial sector. Such regulations are encouraging commercial refrigerator manufacturers to seek low energy consuming refrigerants to minimize the adverse effect of Greenhouse Gas (GHG) emissions. For instance, in 2020, Hiber, a brand of Ali Group S.r.l. a Socio Unico, added bidirectional IoT connectivity integrated refrigeration cabinets optimized with self-learning systems for reducing energy consumption when the equipment is not in use.

In 2020, the COVID-19 catastrophe majorly disrupted the commercial foodservice industry and retail industries, adversely impacting the growth of the market for commercial refrigeration equipment. However, since December 2019, the research institutes and pharmaceutical companies have highly demanded and utilized vaccine storage refrigerators during their R&D processes to come up with a life-saving vaccine against the coronavirus. The commercial refrigeration equipment has witnessed a boom from the biotechnology and pharmaceutical industry owing to the formulation of the vaccine and later its rollout, and for successfully storing and transporting the vaccines at a global scale.

Request a free sample copy or view report summary: Commercial Refrigeration Equipment Market Report

Commercial Refrigeration Equipment Market Report Highlights

  • The refrigerators and freezers segment accounted for a revenue share of nearly 25.0% in 2020. The rising consumption of vaccine storage units during the COVID-19 pandemic in an attempt to conduct a successful immunization process is anticipated to contribute to the growth
  • The U.S. has been the major contributor in the North America region with a revenue share of close to 80.0% in 2020
  • By system type, the self-contained refrigeration equipment segment is expected to register a CAGR of nearly 5.0% from 2021 to 2028
  • The 51 cu. Ft. - 100 cu. Ft. capacity segment accounted for the largest revenue share in 2020

Access Press Release@ https://www.grandviewresearch.com/press-release/global-commercial-refrigeration-equipment-market

Commercial Refrigeration Equipment Market Segmentation

Grand View Research has segmented the global commercial refrigeration equipment market based on product, application, system type, capacity, and region:

Commercial Refrigeration Equipment Product Outlook (Revenue, USD Billion, 2016 - 2028)

  • Transportation Refrigeration Equipment
  • Refrigerators & Freezers
  • Beverage Refrigeration
  • Display Showcases
  • Ice Merchandisers & Ice Vending Equipment
  • Other Equipment

Commercial Refrigeration Equipment Application Outlook (Revenue, USD Billion, 2016 - 2028)

  • Food Service
  • Food & Beverage Retail
    • Hypermarkets
    • Supermarkets
    • Convenience Store
    • Specialty Food Store
    • Others
  • Food & Beverage Distribution
  • Food & Beverage Production
  • Others

Commercial Refrigeration Equipment System Type Outlook (Revenue, USD Billion, 2016 - 2028)

  • Self-contained
  • Remotely Operated

Commercial Refrigeration Equipment Capacity Outlook (Revenue, USD Billion, 2016 - 2028)

  • Less than 50 cu. Ft
  • 50 to 100 cu. Ft
  • More than 100 cu. Ft

Commercial Refrigeration Equipment Regional Outlook (Revenue, USD Billion, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa

List of Key Players of the Commercial Refrigeration Equipment Market

  • AB Electrolux
  • Ali S.p.A.
  • Carrier
  • DAIKIN Industries, Ltd.
  • Dover Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Friday, 21 May 2021

Automotive Natural Gas Vehicle Market Revenue Sales to Reach 38,856.33 Thousand Units by 2028: Grand View Research Inc.

 Automotive Natural Gas Vehicle Market Growth & Trends

The global automotive natural gas vehicle market demand is expected to reach 38,856.33 thousand units by 2028, according to a new report by Grand View Research, Inc. The market is anticipated to register a CAGR of 3.3% from 2021 to 2028. The growing adoption of natural gas as an alternative fuel in vehicles, especially in the transportation sector worldwide, is creating the demand for automotive natural gas vehicles (NGVs). The low emission properties of NGVs facilitated by clean fuel characteristics are expected to drive their demand in public transportation, therefore boosting the market growth. The need for cleaner fuels at lower costs is also expected to drive market growth.

Moreover, government support for the adoption of these vehicles will augment the demand. The government authorities in various countries are implementing stringent regulations to curb environmental damages arising from the emission of Particulate Matter (PM) and Greenhouse Gases (GHG) from vehicles. Simultaneously, with these regulations, authorities have also been continuously revising the emission standard policies to help protect the environment.

Government agencies across the globe are rolling out incentive programs to promote the adoption of NGVs owing to the high initial cost associated with the procurement of CNG and LNG vehicles. Some of the incentive programs to promote the adoption of these vehicles include the U.S. Congestion Mitigation and Air Quality Improvement Program (CMAQ), U.S. Environmental Protection Agency's (EPA) Diesel Emissions Reduction Act Program (DERA), and California Energy Commission’s Clean Transportation Program.

The governments in various countries are undertaking initiatives to develop and expand the natural gas distribution infrastructure and invest significantly in improving natural gas technology. The network of CNG and LNG refueling stations is expanding in various countries, boosting the adoption of NGVs. For instance, the Indian Ministry of Petroleum and Natural Gas announced the construction of 1000 LNG fueling stations on the major national highways across the country. The fueling stations will be commissioned by state-controlled companies, including Hindustan Petroleum (HPCL), IOC, and Bharat Petroleum (BPCL), and gas suppliers such as Gas Authority of India Ltd. (GAIL), Gujrat Gas, and Petronet LNG.

Asia Pacific held the largest share of the overall market in 2020 owing to the increased adoption of natural gas, such as CNG and LNG, in passenger cars, trucks, buses, and three-wheelers in countries, such as India, China, Thailand, Pakistan, and Bangladesh. The region has also emerged as a hub for automotive production in recent years.

Request a free sample copy or view report summary: Automotive Natural Gas Vehicle Market Report

Automotive Natural Gas Vehicle Market Report Highlights

  • Stringent regulations laid down by governments of various nations to reduce the emissions of GHG and PM are expected to positively influence the market growth over the forecast period
  • Refueling solutions, such as home refueling and time-fill refueling, prove to be economical, along with providing convenience to customers
  • The CNG segment dominated the market in 2020 and is anticipated to reach a demand of 36,758.09 thousand units by 2028, owing to less noise produced from a CNG engine due to the lower level of the sound pressure
  • Asia Pacific held the largest market share in 2020. This growth is attributed to the increased production and sales of passenger cars in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-automotive-natural-gas-vehicles-ngv-market

Automotive Natural Gas Vehicle Market Segmentation

Grand View Research has segmented the global automotive natural gas vehicle market on the basis of fuel type, vehicle type, and region:

Automotive NGV Fuel Type Outlook (Volume, Thousand Units, 2016 - 2028)

  • CNG
  • LNG

Automotive NGV Vehicle Type Outlook (Volume, Thousand Units, 2016 - 2028)

  • Passenger
  • Light-duty & Heavy-duty Buses and Trucks
  • Three-wheelers

Automotive NGV Regional Outlook (Volume, Thousand Units, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Russia
    • Germany
    • France
    • Sweden
  • Asia Pacific
    • China
    • India
    • Bangladesh
    • Thailand
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa (MEA)

List of Key Players of Automotive Natural Gas Vehicle (NGV) Market

  • Agility Fuel Solutions
  • AB Volvo
  • Beiqi Foton Motor Co., Ltd.
  • CNH Industrial N.V.
  • Clean Energy Fuels
  • Cummins, Inc.
  • PACCAR, Inc.
  • Navistar, Inc.
  • Quantum Fuel Systems LLC
  • Westport Fuel Systems Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Laboratory Information Management System Market Technological Advancements And Mounting Demand by 2028

 

Laboratory Information Management System Market Growth & Trends

The global laboratory information management system market size is expected to reach USD 1.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.0% from 2021 to 2028. Factors contributing to the growth of the laboratory information management system (LIMS) market include growing demand for laboratory automation, investments in life sciences industry, demand for outsourcing, and technological advancements.

To help in tackling the effect of COVID-19, market players aimed at launching novel solutions in the market. For instance, LabVantage launched the COVID-19 LIMS which is helpful in managing the unprecedented acceleration of the laboratory workflow and volume due to the pandemic. Likewise, in March 2020, Ovation, a U.S. based startup launched an initiative that was centered on its cloud-based LIMS and was aimed towards enabling independent laboratories to broaden their capabilities and effectively doubling the testing capacity throughout the country.

Increasing investment in R&D sectors by pharma and biotechnological organizations is another factor propelling the growth of laboratory information management system. According to National Science Foundation (NSF) data in 2018, the spending on R&D has been increased by approximately 3.2% between 2015 and 2017. Increase in demand for laboratory automation is expected to fuel market growth.

Request a free sample copy or view report summary: Laboratory Information Management System Market Report

Laboratory Information Management System Market Report Highlights

  • The cloud-based segment dominated the market and accounted for the largest revenue share in 2020. The segment is projected to show a CAGR of over 4.6% from 2021 to 2028. Technological advancements by market players are expected to drive the segment
  • The services component segment accounted for the largest revenue share owing to the rising lab automation which required implementation, maintenance, and support
  • North America held the largest revenue share in 2020, due to the favorable government initiatives, demand for genomic studies, and increased investment in R&D by the government
  • The industry participants are focusing on investing in acquisitions, collaborations, product launches, and partnerships to gain a competitive edge
  • The CRO segment is expected to exhibit the lucrative CAGR of 4.6% due to increasing demand for outsourcing LIMS solutions to curb the operating cost
  • In Asia Pacific, the market is anticipated to witness lucrative growth of around 5.4% owing to the rising demand for outsourcing and increasing expenditure in the R&D sector
  • In February 2020, LabVantage Solutions announced the availability of a SaaS package for its purpose-built LIMS platform

Access Press Release@ https://www.grandviewresearch.com/press-release/global-laboratory-information-management-system-lims-market

Laboratory Information Management System Market Segmentation

Grand View Research has segmented the global laboratory information management system market on the basis of product, component, end-use, and region:

LIMS Product Outlook (Revenue, USD Million, 2016 - 2028)

  • On-premise
  • Web-hosted
  • Cloud-based

LIMS Component Outlook (Revenue, USD Million, 2016 - 2028)

  • Software
  • Services

LIMS End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Life Sciences
  • CROs
  • Petrochemical Refineries & Oil and Gas Industry
  • Chemical Industry
  • Food and Beverage and Agriculture Industries
  • Environmental Testing Laboratories
  • Other Industries (Forensics and Metal & Mining Laboratories)

LIMS Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

List of Key Players of Laboratory Information Management System (LIMS) Market

  • Thermo Fisher Scientific
  • Siemens
  • LabVantage Solutions Inc.
  • LabWare
  • PerkinElmer Inc.
  • Abbott Laboratories
  • Autoscribe Informatics
  • Illumina, Inc.
  • Labworks
  • LabLynx, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Polyester Polyol Market to Expand at a CAGR of 5.1% Through 2033: Grand View Research Inc.

  Polyester Polyol Market Growth & Trends The global  polyester polyol market  size is anticipated to reach USD 15,033.3 million by 2033...